These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30845161)

  • 21. Untranslated region-dependent exclusive expression of high-sensitivity subforms of alpha4beta2 and alpha3beta2 nicotinic acetylcholine receptors.
    Briggs CA; Gubbins EJ; Marks MJ; Putman CB; Thimmapaya R; Meyer MD; Surowy CS
    Mol Pharmacol; 2006 Jul; 70(1):227-40. PubMed ID: 16569710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unraveling amino acid residues critical for allosteric potentiation of (α4)3(β2)2-type nicotinic acetylcholine receptor responses.
    Wang ZJ; Deba F; Mohamed TS; Chiara DC; Ramos K; Hamouda AK
    J Biol Chem; 2017 Jun; 292(24):9988-10001. PubMed ID: 28446611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stoichiometry and pharmacology of two human alpha4beta2 nicotinic receptor types.
    Moroni M; Bermudez I
    J Mol Neurosci; 2006; 30(1-2):95-6. PubMed ID: 17192644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy Reduces Low-Sensitivity α4β2, and Increases α5α4β2, Nicotinic Receptor Surface Expression.
    Nichols WA; Henderson BJ; Marotta CB; Yu CY; Richards C; Dougherty DA; Lester HA; Cohen BN
    PLoS One; 2016; 11(6):e0158032. PubMed ID: 27336596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. α4β2 Nicotinic Acetylcholine Receptors: RELATIONSHIPS BETWEEN SUBUNIT STOICHIOMETRY AND FUNCTION AT THE SINGLE CHANNEL LEVEL.
    Mazzaferro S; Bermudez I; Sine SM
    J Biol Chem; 2017 Feb; 292(7):2729-2740. PubMed ID: 28031459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Desformylflustrabromine Modulates α4β2 Neuronal Nicotinic Acetylcholine Receptor High- and Low-Sensitivity Isoforms at Allosteric Clefts Containing the β2 Subunit.
    Weltzin MM; Schulte MK
    J Pharmacol Exp Ther; 2015 Aug; 354(2):184-94. PubMed ID: 26025967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human alpha4beta2 acetylcholine receptors formed from linked subunits.
    Zhou Y; Nelson ME; Kuryatov A; Choi C; Cooper J; Lindstrom J
    J Neurosci; 2003 Oct; 23(27):9004-15. PubMed ID: 14534234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing potentiation of the (α4)3(β2)2 nicotinic acetylcholine receptor by the allosteric agonist CMPI.
    Deba F; Munoz K; Peredia E; Akk G; Hamouda AK
    J Biol Chem; 2022 Jan; 298(1):101455. PubMed ID: 34861241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective potentiation of (α4)3(β2)2 nicotinic acetylcholine receptors augments amplitudes of prefrontal acetylcholine- and nicotine-evoked glutamatergic transients in rats.
    Grupe M; Paolone G; Jensen AA; Sandager-Nielsen K; Sarter M; Grunnet M
    Biochem Pharmacol; 2013 Nov; 86(10):1487-96. PubMed ID: 24051136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineering α4β2 nAChRs with reduced or increased nicotine sensitivity via selective disruption of consensus sites in the M3-M4 cytoplasmic loop of the α4 subunit.
    Biaggi-Labiosa NM; Avilés-Pagán E; Caballero-Rivera D; Báez-Pagán CA; Lasalde-Dominicci JA
    Neuropharmacology; 2015 Dec; 99():273-84. PubMed ID: 25957813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors.
    Wu J; Liu Q; Yu K; Hu J; Kuo YP; Segerberg M; St John PA; Lukas RJ
    J Physiol; 2006 Oct; 576(Pt 1):103-18. PubMed ID: 16825297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nicotine-induced up-regulation and desensitization of alpha4beta2 neuronal nicotinic receptors depend on subunit ratio.
    López-Hernández GY; Sánchez-Padilla J; Ortiz-Acevedo A; Lizardi-Ortiz J; Salas-Vincenty J; Rojas LV; Lasalde-Dominicci JA
    J Biol Chem; 2004 Sep; 279(36):38007-15. PubMed ID: 15247303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation of a neuronal nicotinic receptor via pseudo-agonist site.
    Mazzaferro S; Bermudez I; Sine SM
    Cell Mol Life Sci; 2019 Mar; 76(6):1151-1167. PubMed ID: 30600358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentiation of (α4)2(β2)3, but not (α4)3(β2)2, nicotinic acetylcholine receptors reduces nicotine self-administration and withdrawal symptoms.
    Hamouda AK; Bautista MR; Akinola LS; Alkhlaif Y; Jackson A; Carper M; Toma WB; Garai S; Chen YC; Thakur GA; Fowler CD; Damaj MI
    Neuropharmacology; 2021 Jun; 190():108568. PubMed ID: 33878302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare human nicotinic acetylcholine receptor α4 subunit (CHRNA4) variants affect expression and function of high-affinity nicotinic acetylcholine receptors.
    McClure-Begley TD; Papke RL; Stone KL; Stokes C; Levy AD; Gelernter J; Xie P; Lindstrom J; Picciotto MR
    J Pharmacol Exp Ther; 2014 Mar; 348(3):410-20. PubMed ID: 24385388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partial deletion of the nicotinic cholinergic receptor alpha 4 or beta 2 subunit genes changes the acetylcholine sensitivity of receptor-mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits.
    Gotti C; Moretti M; Meinerz NM; Clementi F; Gaimarri A; Collins AC; Marks MJ
    Mol Pharmacol; 2008 Jun; 73(6):1796-807. PubMed ID: 18337473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Covalent trapping of methyllycaconitine at the α4-α4 interface of the α4β2 nicotinic acetylcholine receptor: antagonist binding site and mode of receptor inhibition revealed.
    Absalom NL; Quek G; Lewis TM; Qudah T; von Arenstorff I; Ambrus JI; Harpsøe K; Karim N; Balle T; McLeod MD; Chebib M
    J Biol Chem; 2013 Sep; 288(37):26521-32. PubMed ID: 23893416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying the binding site of novel methyllycaconitine (MLA) analogs at α4β2 nicotinic acetylcholine receptors.
    Quek GX; Lin D; Halliday JI; Absalom N; Ambrus JI; Thompson AJ; Lochner M; Lummis SC; McLeod MD; Chebib M
    ACS Chem Neurosci; 2010 Dec; 1(12):796-809. PubMed ID: 22778816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The (
    DeDominicis KE; Sahibzada N; Olson TT; Xiao Y; Wolfe BB; Kellar KJ; Yasuda RP
    Mol Pharmacol; 2017 Sep; 92(3):327-337. PubMed ID: 28698187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketamine and its preservative, benzethonium chloride, both inhibit human recombinant alpha7 and alpha4beta2 neuronal nicotinic acetylcholine receptors in Xenopus oocytes.
    Coates KM; Flood P
    Br J Pharmacol; 2001 Oct; 134(4):871-9. PubMed ID: 11606328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.